Via Munich office, Kurma launches oncology company Tacalyx

French VC’s company creation office in Munich yields first start-up, a Max Planck Institute spinout

Tacalyx, the first company created from French VC Kurma’s new Munich office, signals continued interest in tumor-associated carbohydrate antigens (TACAs), the targeting of sugars up-regulated in cancers.

Kurma Partners opened the German office early this year with the intention of creating start-ups based on academic research

Read the full 450 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE